Organism name | Sophora davidii |
---|---|
Genus | Sophora |
Family | Fabaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Sophora davidii |
---|---|
Linked NCBI taxonomy ID | 49839 |
Linked level | species |
Family in NCBI taxonomy | Fabaceae |
---|---|
ID | 3803 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004362
![]() |
Diosmin
/ Luteolin 4'-methyl ether 7-rutinoside / 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside |
CHEMBL231884
CHEMBL1512770 CHEMBL1707291 |
D004145
|
20 / 8 / 14 | 1 / 5 | No. 1 | No. 15 |
![]() |
C00008364
![]() |
Norkurarinone
/ Sophoraflavanone G |
CHEMBL243148
CHEMBL479477 |
C064849
|
3 / 2 / 2 | No. 19 | No. 14 |
![]() |
|
C00008433
![]() |
Leachianone A
|
CHEMBL453642
CHEMBL519096 |
1 / 0 / 0 | No. 19 | No. 14 |
![]() |
||
C00002227
![]() |
Matrine
/ (+)-Matrine |
CHEMBL204860
CHEMBL383443 CHEMBL525227 CHEMBL1396816 CHEMBL1733145 CHEMBL1824581 |
C034244
|
5 / 3 / 7 | 4 / 5 | No. 85 | No. 3 |
![]() |
C00002209
![]() |
Aphylline
|
CHEMBL509343
|
No. 85 | No. 3 |
![]() |
|||
C00037006
![]() |
Davidiol C
|
No. 93 |
![]() |
|||||
C00002905
![]() |
epsilon-Viniferin
/ (-)-epsilon-Viniferin |
CHEMBL498439
CHEMBL1224875 CHEMBL1224889 |
C091891
|
9 / 0 | No. 108 | No. 30 |
![]() |
|
C00015825
![]() |
Miyabenol C
/ trans-Miyabenol |
No. 163 | No. 30 |
![]() |
||||
C00015693
![]() |
lpha-Viniferin
/ (+)-alpha-Viniferin |
CHEMBL443463
CHEMBL1997745 |
C064176
|
1 / 0 / 3 | 1 / 2 | No. 163 | No. 30 |
![]() |
C00032889
![]() |
Davidiol A
/ (-)-Davidiol A |
CHEMBL466300
|
No. 163 | No. 30 |
![]() |
|||
C00037005
![]() |
Davidiol B
|
No. 163 | No. 30 |
![]() |
||||
C00002219
![]() |
5,6-Dehydrolupanine
|
No. 555 | No. 3 |
![]() |
||||
C00015872
![]() |
Sophoraflavanone H
|
No. 669 |
![]() |
|||||
C00008525
![]() |
Sophoraflavanone I
|
No. 669 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002227 C00004362 | 1 / 2 |
O00255 | Menin | Unclassified protein | C00002227 C00004362 | 2 / 5 |
P56817 | Beta-secretase 1 | A1A | C00008364 C00008433 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002227 C00004362 | 0 / 0 |
P13866 | Sodium/glucose cotransporter 1 | Glucose | C00008364 | 1 / 1 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002227 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00004362 | 2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00004362 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00004362 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00004362 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00004362 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00004362 | 1 / 2 |
Q9Y253 | DNA polymerase eta | Enzyme | C00004362 | 1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00004362 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00004362 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002227 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00015693 | 0 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00004362 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00004362 | 0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00004362 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00004362 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00004362 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00004362 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00004362 | 1 / 1 |
P31639 | Sodium/glucose cotransporter 2 | Glucose | C00008364 | 1 / 1 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00004362 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00002905
C00015693
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00002905
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00002227
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002227
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00002227
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002905
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00002905
|
4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog |
C00002227
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002905
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00002905
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00002905
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00002905
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00002905
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00004362
|
OMIM | preferred title | UniProt |
---|---|---|
#606824 | Glucose/galactose malabsorption; ggm |
P13866
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#233100 | Renal glucosuria; glys1 |
P31639
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01261 | Congenital glucose-galactose malabsorption (GGM) |
P13866
(related)
|
H01126 | Familial renal glucosuria (FRG) |
P31639
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00016 | Oral cancer |
P40763
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00002227
|
D002779 | Cholestasis |
C00002227
|
D056487 | Drug-Induced Liver Injury, Chronic |
C00002227
|
D006331 | Heart Diseases |
C00002227
|
D008113 | Liver Neoplasms |
C00002227
|
D004487 | Edema |
C00015693
|
D007249 | Inflammation |
C00015693
|
D003921 | Diabetes Mellitus, Experimental |
C00004362
|
D003924 | Diabetes Mellitus, Type 2 |
C00004362
|
D056486 | Drug-Induced Liver Injury |
C00004362
|
D006501 | Hepatic Encephalopathy |
C00004362
|
D007565 | Jaundice |
C00004362
|